Håkon Sæterøy, CEO and Co-founder
With +30 years of experience in management, corporate finance and business development, Sæterøy has developed an extensive international network within the industry and investor communities . He has broad experience from board positions in several Norwegian companies, including being longstanding Executive Chairman of diagnostic companies DiaGenic ASA and Serodus ASA. He has previously served as chairman of the board of Nansen Neuroscience Network and as a board member of Oslo Cancer Cluster. He remains an active board member in a several life science companies. Sæterøy holds a Master in Business from the Norwegian School of Economics.
Erik Christensen, CMO and Co-founder
Christensen has 30+ years of experience from the diagnostics industry, including as CEO of diagnostic company DiaGenic ASA, as Nordic Medical Director subsequently as Country Manager for Abbott’s Diagnostic division in Norway. He has extensive experience from clinical practice, serving as senior consultant in Clinical Chemistry at Rikshospitalet and Ullevål University Hospital, holds a medical degree from Odense University, and earned his PhD peroxisomal ß-oxidation of fatty acids from the University of Oslo. He is a certified Clinical Pathologists by the Norwegian Medical Association and is a longstanding advisor to the Norwegian Research Council.
Charlotte Berg-Svendsen, CCO
Berg-Svendsen has broad international experience from various leadership positions within the nutrition, pharma and health industry, latest as Vice President and General Manager of BASF’s global omega-3 business where she was also responsible for commercialization of new products. She has held several board positions in the life science industry, and currently serves as a member of the board in Nansen Neuroscience Network and Kappa Biosciences. She holds an LLM from the University of Oslo, a Diploma in English Commercial Law from College of London and is currently enrolled in the executive MBA program at the Norwegian School of Economics.